# Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy Subjects

> **NCT05141110** · PHASE1 · COMPLETED · sponsor: **NVP Healthcare** · enrollment: 50 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** NVP-1705
- **DRUG:** NVP-1705-R

## Key facts

- **NCT ID:** NCT05141110
- **Lead sponsor:** NVP Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-29
- **Primary completion:** 2022-04-27
- **Final completion:** 2022-06-29
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05141110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05141110, "Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05141110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*